Regulation of endothelial cell survival and apoptosis during angiogenesis

被引:232
作者
Chavakis, E [1 ]
Dimmeler, S [1 ]
机构
[1] Univ Frankfurt, Dept Internal Med 4, D-60590 Frankfurt, Germany
关键词
apoptosis; angiogenesis; growth factors; vascular endothelial growth factor; angiopoietin;
D O I
10.1161/01.ATV.0000017728.55907.A9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The process of angiogenesis plays an important role in many physiological and pathological conditions. Inhibition of endothelial cell (EC) apoptosis providing EC survival is thought to be an essential mechanism during angiogenesis. Many of the angiogenic growth factors inhibit EC apoptosis. In addition, the adhesion of ECs to the extracellular matrix or intercellular adhesion promotes EC survival. In contrast, increasing evidence suggests that the induction of EC apoptosis may counteract angiogenesis. In this review, we focus on the regulation of EC survival and apoptosis during angiogenesis and especially on the effects and intracellular signaling promoted by angiogenic growth factors, endogenous angiogenic inhibitors (such as angiostatin, endostatin, and thrombospondin-1), and the adhesion to the extracellular matrix. Furthermore, we discuss the effects of cross talk between adhesion molecules and growth factors. Understanding the molecular mechanisms involved in the regulation of EC survival and apoptosis may provide new targets for the development of new therapies to enhance angiogenesis in the case of tissue-ischemia (eg, the neovascularization of myocardium) or to inhibit angiogenesis in the case of neovascularization-dependent disease (eg, tumor, diabetic retinopathy).
引用
收藏
页码:887 / 893
页数:7
相关论文
共 92 条
  • [1] VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY
    ALON, T
    HEMO, I
    ITIN, A
    PEER, J
    STONE, J
    KESHET, E
    [J]. NATURE MEDICINE, 1995, 1 (10) : 1024 - 1028
  • [2] Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins
    Bader, BL
    Rayburn, H
    Crowley, D
    Hynes, RO
    [J]. CELL, 1998, 95 (04) : 507 - 519
  • [3] Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
    Benjamin, LE
    Keshet, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) : 8761 - 8766
  • [4] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    Benjamin, LE
    Golijanin, D
    Itin, A
    Pode, D
    Keshet, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 159 - 165
  • [5] Bird IN, 1999, J CELL SCI, V112, P1989
  • [6] beta 1 integrin is essential for teratoma growth and angiogenesis
    Bloch, W
    Forsberg, E
    Lentini, S
    Brakebusch, C
    Martin, K
    Krell, HW
    Weidle, UH
    Addicks, K
    Fassler, R
    [J]. JOURNAL OF CELL BIOLOGY, 1997, 139 (01) : 265 - 278
  • [7] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS
    BROOKS, PC
    CLARK, RAF
    CHERESH, DA
    [J]. SCIENCE, 1994, 264 (5158) : 569 - 571
  • [8] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS
    BROOKS, PC
    MONTGOMERY, AMP
    ROSENFELD, M
    REISFELD, RA
    HU, TH
    KLIER, G
    CHERESH, DA
    [J]. CELL, 1994, 79 (07) : 1157 - 1164
  • [9] A mechanism for modulation of cellular responses to VEGF: Activation of the integrins
    Byzova, TV
    Goldman, CK
    Pampori, N
    Thomas, KA
    Bett, A
    Shattil, SJ
    Plow, EF
    [J]. MOLECULAR CELL, 2000, 6 (04) : 851 - 860
  • [10] Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
    Carmeliet, P
    Lampugnani, MG
    Moons, L
    Breviario, F
    Compernolle, V
    Bono, F
    Balconi, G
    Spagnuolo, R
    Oosthuyse, B
    Dewerchin, M
    Zanetti, A
    Angellilo, A
    Mattot, V
    Nuyens, D
    Lutgens, E
    Clotman, F
    de Ruiter, MC
    Gittenberger-de Groot, A
    Poelmann, R
    Lupu, F
    Herbert, JM
    Collen, D
    Dejana, E
    [J]. CELL, 1999, 98 (02) : 147 - 157